Rejected at 3:07 p.m. Nov, 11, 2023 ] by Ahmed7
Author: haithamkayal
Related Note: 1487815419465 1
Rationale for change

Anti-histone antibodies is highly specific for drug-induced lupus.

Rejection reason

Please resubmit with an acceptable source. Please review suggestion guidelines: http://www.theanking.com/decks/step/suggestions

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::AnKing_Image::Michael #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Rheumatology::Approach_to_Joint_Pain #AK_Step3_v12::#UWorld::9968 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Pathoma_Chapter_2_(Inflammation) #AK_Step1_v12::#Low/HighYield::4-LowerYield #AK_Step2_v12::#AMBOSS::xZaEdQ #AK_Step2_v12::Original_decks::Dorian::fam::ome::rheum::joint_pain_approach #AK_Step2_v12::Original_decks::Dorian::im::ome::rheum::joint_pain_approach #AK_Step2_v12::#Resources_by_rotation::IM::ome::rheum::lupus #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::25_Systemic_lupus_erythematosus #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::15_Autoantibodies #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::03_Scleroderma #AK_Step1_v12::#AMBOSS::xZaEdQ #AK_Step2_v12::#Resources_by_rotation::IM::uw::rheum/ortho::rheum/ortho_dorian #AK_Step2_v12::#OME::01_Medicine::08_Rheumatology::01_Approach_to_Joint_Pain #AK_Step2_v12::#Resources_by_rotation::FM::ome::rheum::joint_pain_approach #AK_Step2_v12::Original_decks::Dorian::im::uw::rheum/ortho #AK_Step2_v12::#SketchyIM::07_Rheumatology::01_Approach_To_Clinical_Conditions::02_Autoantibodies_In_Rheumatic_Diseases #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::#B&B::04_Biochem::01_Molecular::01_DNA_Structure #AK_Step1_v12::#Pathoma::02_Inflammation::04_Autoimmune_Disorders::2 #AK_Step1_v12::#AMBOSS #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::04_Antihypertensives_II #AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::06_Antihypertensives #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::22_Hydralazine #AK_Step1_v12::#B&B::13_Immunology::04_Autoimmune_Disorders::01_Systemic_Lupus_Erythematosus #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::02_Systemic_Lupus_Erythematosus_SOAP #AK_Step2_v12::#Resources_by_rotation::IM::ome::rheum::joint_pain_approach #AK_Step1_v12::#SketchyPath::11_Immunology::01_Autoimmune_&_Amyloidosis::01_Autoimmune_Disease:_Overview_&_Systemic_Lupus_Erythematosus_(SLE) #AK_Step1_v12::#DirtyMedicine::04_Pathology::05_Autoantibodies_Rapid_Review #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::02_Systemic_Lupus_Erythematosus #AK_Step2_v12::#OME::01_Medicine::08_Rheumatology::02_Lupus #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::Original_decks::Dorian::im::ome::rheum::lupus #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#B&B::09_MSK::01_General::04_Systemic_Lupus_Erythematosus #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::22_Isoniazid